相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Broad Cytotoxic Targeting of Acute Myeloid Leukemia by Polyclonal Delta One T Cells
Biagio Di Lorenzo et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Evaluating in vivo efficacy - toxicity profile of TEG001 in humanized mice xenografts against primary human AML disease and healthy hematopoietic cells
Inez Johanna et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Monkeying Around: Using Non-human Primate Models to Study NK Cell Biology in HIV Infections
Cordelia Manickam et al.
FRONTIERS IN IMMUNOLOGY (2019)
A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells
Renee C. G. de Bruin et al.
ONCOIMMUNOLOGY (2018)
Early Reconstitution of NK and gamma delta T Cells and Its Implication for the Design of Post-Transplant Immunotherapy
Moniek A. de Witte et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
The potential role of gamma delta T cells after allogeneic HCT for leukemia
Rupert Handgretinger et al.
BLOOD (2018)
Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
Ye Li et al.
CELL STEM CELL (2018)
Kinase-targeted cancer therapies: progress, challenges and future directions
Khushwant S. Bhullar et al.
MOLECULAR CANCER (2018)
Chimeric Antigen Receptor-Engineered Human Gamma Delta T Cells: Enhanced Cytotoxicity with Retention of Cross Presentation
Anna Capsomidis et al.
MOLECULAR THERAPY (2018)
Heteromeric interactions regulate butyrophilin (BTN) and BTN-like molecules governing gamma delta T cell biology
Pierre Vantourout et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
gamma delta T cell responses: How many ligands will it take till we know?
David Vermijlen et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2018)
Butyrophilin3A proteins and V gamma 9V delta 2 T cell activation
Siyi Gu et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2018)
The human Vδ2+ T-cell compartment comprises distinct innate-like Vγ9+ and adaptive Vγ9- subsets
Martin S. Davey et al.
NATURE COMMUNICATIONS (2018)
Towards Deciphering the Hidden Mechanisms That Contribute to the Antigenic Activation Process of Human Vγ9Vδ2 T Cells
Lola Boutin et al.
FRONTIERS IN IMMUNOLOGY (2018)
Molecular Determinants of Target Cell Recognition by Human γδ T Cells
Andre E. Simoes et al.
FRONTIERS IN IMMUNOLOGY (2018)
GMP-Grade Manufacturing of T Cells Engineered to Express a Defined γδTCR
Trudy Straetemans et al.
FRONTIERS IN IMMUNOLOGY (2018)
Engineering Approaches in Human Gamma Delta T Cells for Cancer Immunotherapy
Jonathan Fisher et al.
FRONTIERS IN IMMUNOLOGY (2018)
Next-Generation Sequencing Analysis of the Human TCRγδ plus T-Cell Repertoire Reveals Shifts in Vγ- and Vδ-Usage in Memory Populations upon Aging
Martine J. Kallemeijn et al.
FRONTIERS IN IMMUNOLOGY (2018)
Human γδ T-Cell Control of Mucosal immunity and inflammation
Neil E. McCarthy et al.
FRONTIERS IN IMMUNOLOGY (2018)
Development and Selection of the Human Vγ9Vδ2+ T-Cell Repertoire
Carrie R. Willcox et al.
FRONTIERS IN IMMUNOLOGY (2018)
Potential Beneficial effects of Cytomegalovirus infection after Transplantation
Nicolle H. R. Litjens et al.
FRONTIERS IN IMMUNOLOGY (2018)
Cellular immunotherapy on primary multiple myeloma expanded in a 3D bone marrow niche model
Maaike V. J. Braham et al.
ONCOIMMUNOLOGY (2018)
Improving CLL V gamma 9V delta 2-T-cell fitness for cellular therapy by ex vivo activation and ibrutinib
Iris de Weerdt et al.
BLOOD (2018)
Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids
Krijn K. Dijkstra et al.
CELL (2018)
CD38 Antibodies in Multiple Myeloma: Mechanisms of Action and Modes of Resistance
Niels W. C. J. van de Donk et al.
FRONTIERS IN IMMUNOLOGY (2018)
Genetic models reveal origin, persistence and non-redundant functions of IL-17-producing gamma delta T cells
Inga Sandrock et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Cancer immunologists scoop medicine Nobel prize
Heidi Ledford et al.
NATURE (2018)
The gamma delta TCR combines innate immunity with adaptive immunity by utilizing spatially distinct regions for agonist selection and antigen responsiveness
Daisy Melandri et al.
NATURE IMMUNOLOGY (2018)
Generation and molecular recognition of melanoma-associated antigen-specific human γδ T cells
Patricia M. Benveniste et al.
SCIENCE IMMUNOLOGY (2018)
The butyrophilin 3A1 intracellular domain undergoes a conformational change involving the juxtamembrane region
Khiem Nguyen et al.
FASEB JOURNAL (2017)
The Juxtamembrane Domain of Butyrophilin BTN3A1 Controls Phosphoantigen-Mediated Activation of Human Vγ9Vδ2 T Cells
Cassie-Marie Peigne et al.
JOURNAL OF IMMUNOLOGY (2017)
Adoptive Transfer of Phosphoantigen- Specific γδT Cell Subset Attenuates Mycobacterium tuberculosis Infection in Nonhuman Primates
Arwa Qaqish et al.
JOURNAL OF IMMUNOLOGY (2017)
Nature Biotechnology's academic spinouts of 2016
Aaron Bouchie et al.
NATURE BIOTECHNOLOGY (2017)
Sensing of cell stress by human γδ TCR-dependent recognition of annexin A2
Romain Marlin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Phosphoantigen-induced conformational change of butyrophilin 3A1 (BTN3A1) and its implication on Vγ9Vδ2 T cell activation
Siyi Gu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
The Ambiguous Role of γδ T Lymphocytes in Antitumor Immunity
Guranda Chitadze et al.
TRENDS IN IMMUNOLOGY (2017)
Clonal selection in the human Vδ1 T cell repertoire indicates γδ TCR-dependent adaptive immune surveillance
Martin S. Davey et al.
NATURE COMMUNICATIONS (2017)
Tumor-infiltrating gamma delta T cells predict prognosis and adjuvant chemotherapeutic benefit in patients with gastric cancer
Jieti Wang et al.
ONCOIMMUNOLOGY (2017)
Assessment of tumor-infiltrating TCRVγ9Vδ2 γδ lymphocyte abundance by deconvolution of human cancers microarrays
Marie Tosolini et al.
ONCOIMMUNOLOGY (2017)
Distinctive features of tumor-infiltrating γδ T lymphocytes in human colorectal cancer
S. Meraviglia et al.
ONCOIMMUNOLOGY (2017)
Vγ9Vδ2 T cell activation by strongly agonistic nucleotidic phosphoantigens
Morgane Moulin et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
Clinical development of CAR T cells-challenges and opportunities in translating innovative treatment concepts
Jessica Hartmann et al.
EMBO MOLECULAR MEDICINE (2017)
γδ T Cells: Unexpected Regulators of Cancer Development and Progression
Christopher Fleming et al.
TRENDS IN CANCER (2017)
Butyrophilin 3A (BTN3A, CD277)-specific antibody 20.1 differentially activates Vγ9Vδ2 TCR clonotypes and interferes with phosphoantigen activation
Lisa Starick et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Adjuvant combination therapy with gemcitabine and autologous γδ T-cell transfer in patients with curatively resected pancreatic cancer
Taku Aoki et al.
CYTOTHERAPY (2017)
Human γδ T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infection
Sarina Ravens et al.
NATURE IMMUNOLOGY (2017)
Epithelia Use Butyrophilin-like Molecules to Shape Organ-Specific γδ T Cell Compartments
Rafael Di Marco Barros et al.
CELL (2016)
Cancer Immunosurveillance by Tissue-Resident Innate Lymphoid Cells and Innate-like T Cells
Saida Dadi et al.
CELL (2016)
γδ T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation
Donnele Daley et al.
CELL (2016)
The Emerging Hallmarks of Cancer Metabolism
Natalya N. Pavlova et al.
CELL METABOLISM (2016)
Delta One T Cells for Immunotherapy of Chronic Lymphocytic Leukemia: Clinical-Grade Expansion/Differentiation and Preclinical Proof of Concept
Afonso R. Almeida et al.
CLINICAL CANCER RESEARCH (2016)
Protective immune responses of major Vγ2Vδ2 T-cell subset in M. tuberculosis infection
Zheng W. Chen
CURRENT OPINION IN IMMUNOLOGY (2016)
Proportions of blood-borne Vδ1+and Vδ2+T-cells are associated with overall survival of melanoma patients treated with ipilimumab
Kilian Wistuba-Hamprecht et al.
EUROPEAN JOURNAL OF CANCER (2016)
IL17 producing γδT cells induce angiogenesis and are associated with poor survival in gallbladder cancer patients
Rushikesh Sudam Patil et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Chaperonin-containing T-complex Protein 1 Subunit Serves as an Autoantigen Recognized by Human Vδ2 γδ T Cells in Autoimmune Diseases
Hui Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Molecular Analysis of Lipid-Reactive Vδ1 γδ T Cells Identified by CD1c Tetramers
Sobhan Roy et al.
JOURNAL OF IMMUNOLOGY (2016)
In vivo expansion and activation of T cells as immunotherapy for refractory neuroblastoma: A phase 1 study
Joseph G. Pressey et al.
MEDICINE (2016)
Tissue-specific mutation accumulation in human adult stem cells during life
Francis Blokzijl et al.
NATURE (2016)
Heterogeneous yet stable Vδ2(+) T-cell profiles define distinct cytotoxic effector potentials in healthy human individuals
Paul L. Ryan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell Receptor
Zsolt Sebestyen et al.
CELL REPORTS (2016)
Isopentenyl pyrophosphate secreted from Zoledronate-stimulated myeloma cells, activates the chemotaxis of γδT cells
Eishi Ashihara et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Gamma Delta T Cell Reconstitution Is Associated with Fewer Infections and Improved Event-Free Survival after Hematopoietic Stem Cell Transplantation for Pediatric Leukemia
Ross Perko et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Orchestrating an immune response against cancer with engineered immune cells expressing αβTCRs, CARs, and innate immune receptors: an immunological and regulatory challenge
Moniek A. de Witte et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Human gamma delta T cells: Evolution and ligand recognition
Erin J. Adams et al.
CELLULAR IMMUNOLOGY (2015)
Untouched GMP-Ready Purified Engineered Immune Cells to Treat Cancer
Trudy Straetemans et al.
CLINICAL CANCER RESEARCH (2015)
Bispecific antibodies
Roland E. Kontermann et al.
DRUG DISCOVERY TODAY (2015)
Azathioprine therapy selectively ablates human V delta 2(+) T cells in Crohn's disease
Neil E. McCarthy et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Activation of Human γδ T Cells by Cytosolic Interactions of BTN3A1 with Soluble Phosphoantigens and the Cytoskeletal Adaptor Periplakin
David A. Rhodes et al.
JOURNAL OF IMMUNOLOGY (2015)
IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis
Seth B. Coffelt et al.
NATURE (2015)
The prognostic landscape of genes and infiltrating immune cells across human cancers
Andrew J. Gentles et al.
NATURE MEDICINE (2015)
Effector Vγ9Vδ2 T cells dominate the human fetal γδ T-cell repertoire
Tanya Dimova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Direct and indirect effects of cytomegalovirus-induced γδ T cells after kidney transplantation
Lionel Couzi et al.
FRONTIERS IN IMMUNOLOGY (2015)
γδ T Cells: First Line of Defense and Beyond
Yueh-hsiu Chien et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
Oncogenic Kras Activates a Hematopoietic-to-Epithelial IL-17 Signaling Axis in Preinvasive Pancreatic Neoplasia
Florencia McAllister et al.
CANCER CELL (2014)
γδT17 Cells Promote the Accumulation and Expansion of Myeloid-Derived Suppressor Cells in Human Colorectal Cancer
Pin Wu et al.
IMMUNITY (2014)
Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression-free survival for patients with hepatocellular carcinoma
Jiuwei Cui et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
A novel self-lipid antigen targets human T cells against CD1c+ leukemias
Marco Lepore et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Human γδ Thymocytes Are Functionally Immature and Differentiate into Cytotoxic Type 1 Effector T Cells upon IL-2/IL-15 Signaling
Julie C. Ribot et al.
JOURNAL OF IMMUNOLOGY (2014)
Successful adoptive transfer and in vivo expansion of haploidentical γδ T cells
Martin Wilhelm et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Hunting for clinical translation with innate-like immune cells and their receptors
W. Scheper et al.
LEUKEMIA (2014)
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Alexandra Snyder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Murine CD27(-) Vγ6(+) γδ T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophages
Margarida Rei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
γδ T cell surveillance via CD1 molecules
Adrienne M. Luoma et al.
TRENDS IN IMMUNOLOGY (2014)
Intraperitoneal injection of in vitro expanded Vγ9Vδ2 T cells together with zoledronate for the treatment of malignant ascites due to gastric cancer
Ikuo Wada et al.
CANCER MEDICINE (2014)
Cancer immunotherapy using γδT cells: dealing with diversity
Wouter Scheper et al.
FRONTIERS IN IMMUNOLOGY (2014)
Clinical applications of gamma delta T cells with multivalent immunity
Drew C. Deniger et al.
FRONTIERS IN IMMUNOLOGY (2014)
Tumor-infiltrating γδ T lymphocytes: pathogenic role, clinical significance, and differential programing in tumor microenvironment
Elena Lo Presti et al.
FRONTIERS IN IMMUNOLOGY (2014)
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma
Gerald P. Linette et al.
BLOOD (2013)
Specific Recruitment of γδ Regulatory T Cells in Human Breast Cancer
Jian Ye et al.
CANCER RESEARCH (2013)
Ex vivo characterization of γδ T-cell repertoire in patients after adoptive transfer of Vγ9Vδ2 T cells expressing the interleukin-2 receptor β-chain and the common γ-chain
Takamichi Izumi et al.
CYTOTHERAPY (2013)
A Long-Playing CD about the γδ TCR Repertoire
Adrian Hayday et al.
IMMUNITY (2013)
Crystal Structure of Vδ1 T Cell Receptor in Complex with CD1d-Sulfatide Shows MHC-like Recognition of a Self-Lipid by Human γδ T Cells
Adrienne M. Luoma et al.
IMMUNITY (2013)
Cutting Edge: CD1d Restriction and Th1/Th2/Th17 Cytokine Secretion by Human Vδ3 T Cells
Bozgana A. Mangan et al.
JOURNAL OF IMMUNOLOGY (2013)
Tumor-Derived γδ Regulatory T Cells Suppress Innate and Adaptive Immunity through the Induction of Immunosenescence
Jian Ye et al.
JOURNAL OF IMMUNOLOGY (2013)
γδT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia
W. Scheper et al.
LEUKEMIA (2013)
Resolving the mystery of pyrophosphate antigen presentation
Carrie R. Willcox et al.
NATURE IMMUNOLOGY (2013)
CD1d-lipid antigen recognition by the γδ TCR
Adam P. Uldrich et al.
NATURE IMMUNOLOGY (2013)
Engineered Drug Resistant γδ T Cells Kill Glioblastoma Cell Lines during a Chemotherapy Challenge: A Strategy for Combining Chemo- and Immunotherapy
Lawrence S. Lamb et al.
PLOS ONE (2013)
Multifunctional γδ T cells and their receptors for targeted anticancer immunotherapy
Wouter Scheper et al.
ONCOIMMUNOLOGY (2013)
Synthesis of phosphoantigens: Scalable accesses to enantiomers of BrHPP and studies on N-HDMAPP synthesis
Delphine Bregeon et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
γ9 and δ2CDR3 domains regulate functional avidity of T cells harboring γ9δ2TCRs
Cordula Gruender et al.
BLOOD (2012)
Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset
Christelle Harly et al.
BLOOD (2012)
Ectopically Expressed Human Tumor Biomarker MutS Homologue 2 Is a Novel Endogenous Ligand That Is Recognized by Human γδT Cells to Induce Innate Anti-tumor/Virus Immunity
Yumei Dai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Ectopic Expression of Human MutS Homologue 2 on Renal Carcinoma Cells Is Induced by Oxidative Stress with Interleukin-18 Promotion via p38 Mitogen-activated Protein Kinase (MAPK) and c-Jun N-terminal Kinase (JNK) Signaling Pathways
Chen Mo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Tumor-Infiltrating γδ T Lymphocytes Predict Clinical Outcome in Human Breast Cancer
Chunling Ma et al.
JOURNAL OF IMMUNOLOGY (2012)
Tumor-promoting Versus Tumor-antagonizing Roles of γδ T Cells in Cancer Immunotherapy: Results From a Prospective Phase I/II Trial
Volker Kunzmann et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Cytomegalovirus and tumor stress surveillance by binding of a human γδ T cell antigen receptor to endothelial protein C receptor
Carrie R. Willcox et al.
NATURE IMMUNOLOGY (2012)
Analysis of Vδ1T cells in clinical grade melanoma-infiltrating lymphocytes
Marco Donia et al.
ONCOIMMUNOLOGY (2012)
Redirecting αβT cells against cancer cells by transfer of a broadly tumor-reactive γδT-cell receptor
Victoria Marcu-Malina et al.
BLOOD (2011)
Differentiation of human peripheral blood Vδ1+ T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells
Daniel V. Correia et al.
BLOOD (2011)
Differentiation, phenotype, and function of interleukin-17-producing human Vγ9Vδ2 T cells
Nadia Caccamo et al.
BLOOD (2011)
Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours
A. J. Nicol et al.
BRITISH JOURNAL OF CANCER (2011)
Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma
Hirohito Kobayashi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma
Joshua M. Lang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Zoledronate-activated V gamma 9 gamma delta T cell-based immunotherapy is feasible and restores the impairment of gamma delta T cells in patients with solid tumors
Atsutaka Noguchi et al.
CYTOTHERAPY (2011)
Contribution of IL-17-producing γδ T cells to the efficacy of anticancer chemotherapy
Yuting Ma et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Adoptive Immunotherapy for Advanced Non-small Cell Lung Cancer Using Zoledronate-expanded γδ T Cells: A Phase I Clinical Study
Miki Sakamoto et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Deep Sequencing of the Human TCRγ and TCRβ Repertoires Suggests that TCRβ Rearranges After ab and γδ T Cell Commitment
Anna M. Sherwood et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vγ9Vδ2 T lymphocyte agonist in patients with solid tumors
Jaafar Bennouna et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Natural Killer Cell Education and Tolerance
Mark T. Orr et al.
CELL (2010)
A phase I study of adoptive immunotherapy for recurrent non-small-cell lung cancer patients with autologous γδ T cells
Jun Nakajima et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2010)
Tumor-infiltrating IL-17-producing γδ T cells support the progression of tumor by promoting angiogenesis
Daiko Wakita et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
V gamma 2V delta 2 T Cell Receptor Recognition of Prenyl Pyrophosphates Is Dependent on All CDRs
Hong Wang et al.
JOURNAL OF IMMUNOLOGY (2010)
Cytomegalovirus-Induced gamma delta T Cells Associate with Reduced Cancer Risk after Kidney Transplantation
Lionel Couzi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Zoledronic acid and interleukin-2 treatment improves immunocompetence in HIV-infected persons by activating Vγ9Vδ2 T cells
Fabrizio Poccia et al.
AIDS (2009)
Neonates harbour highly active γδ T cells with selective impairments in preterm infants
Deena L. Gibbons et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Clinical and immunological evaluation of zoledronate-activated Vγ9γδ T-cell-based immunotherapy for patients with multiple myeloma
Yu Abe et al.
EXPERIMENTAL HEMATOLOGY (2009)
Specific Requirements for Vγ9Vδ2 T Cell Stimulation by a Natural Adenylated Phosphoantigen
Pierre Vantourout et al.
JOURNAL OF IMMUNOLOGY (2009)
Common Features of γδ T Cells and CD8+ αβ T Cells Responding to Human Cytomegalovirus Infection in Kidney Transplant Recipients
Lionel Couzi et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Long-term expansion of effector/memory Vδ2- γδ T cells is a specific blood signature of CMV infection
Vincent Pitard et al.
BLOOD (2008)
Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma
Jaafar Bennouna et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Skint1, the prototype of a newly identified immunoglobulin superfamily gene cluster, positively selects epidermal γδ T cells
Lynn M. Boyden et al.
NATURE GENETICS (2008)
Tumor-infiltrating γδ T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway
Guangyong Peng et al.
IMMUNITY (2007)
Targeting human γδ T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer
Francesco Dieli et al.
CANCER RESEARCH (2007)
Long term disease-free survival in acute leukemia patients recovering with increased γδ T cells after partiallymismatched related donor bone marrow transplantation
K. T. Godder et al.
BONE MARROW TRANSPLANTATION (2007)
Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study
Hirohito Kobayashi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Synthesis of pyrophosphate-containing compounds that stimulate V gamma 2V delta 2 T cells: Application to cancer immunotherapy
Y. Tanaka et al.
MEDICINAL CHEMISTRY (2007)
Complex interplay of activating and inhibitory signals received by Vγ9Vδ2 T cells revealed by target cell β2-microglobulin knockdown
Valerie Trichet et al.
JOURNAL OF IMMUNOLOGY (2006)
Shared reactivity of V δ2neg γδ T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells
F Halary et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Tumor recognition following V gamma 9V delta 2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I
E Scotet et al.
IMMUNITY (2005)
γδ T cells for immune therapy of patients with lymphoid malignancies
M Wilhelm et al.
BLOOD (2003)
Microbial isoprenoid biosynthesis and human γδ T cell activation
M Eberl et al.
FEBS LETTERS (2003)
Human T cell receptor γδ cells recognize endogenous mevalonate metabolites in tumor cells
HJ Gober et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
γδ T cells:: Functional plasticity and heterogeneity
SR Carding et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Regulation of cutaneous malignancy by γδ T cells
M Girardi et al.
SCIENCE (2001)
分享论文
